Silver Book Fact

Spending $1,000 per year on anticoagulants can save $100,000 in hospital costs for care of a person disabled by a stroke.

Giorgianni, Salvatore J., John Grana, and Lisa Scipioni. Global Impact of Innovations on Chronic Disease in the Genomics Era. The Pfizer Journal. 01-Nov-2001; 11

Reference

Title
Global Impact of Innovations on Chronic Disease in the Genomics Era
Publication
The Pfizer Journal
Publisher
Pfizer Inc
Publication Date
01-Nov-2001
Authors
Giorgianni, Salvatore J., John Grana, and Lisa Scipioni

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • If antihypertensive medication were widely used, it would result in an estimated increase in life expectancy (averaged over the entire population) of 0.5 years in men and 0.4 years in…  
  • Stroke rates among Afib patients
    In one year, 58,283 of the 1.265 million Medicare beneficiaries with atrial fibrillation that did not receive prophylaxis suffered a stroke. For those who did receive anti-coagulants, 38,468 suffered strokes.  
  • Effects of optimal anticoagulation among AFib patients
    If 50% of individuals with atrial fibrillation who do not receive prophylaxis were optimally anti-coagulated, 19,380 emboli would be prevented and $1.1 billion would be saved each year.  
  • Anti-platelet therapy stroke risk reduction
    Anti-platelet therapy after a stroke or TIA reduces the risk of nonfatal ischemic strokes by 28% and fatal strokes by 16%.  
  • According to the National Center for Health Statistics, if all major forms of cardiovascular disease were eliminated, life expectancy would rise by close to 7 years.